Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Trifilieff

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidateNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2014
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonistNicola Arnold, David Beattie, Michelle Bradley, et al.
Journal of Medicinal Chemistry|April 21, 2010
The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonistFrançois Baur, David Beattie, David Beer, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidateNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2014
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonistNicola Arnold, David Beattie, Michelle Bradley, et al.
Journal of Medicinal Chemistry|April 21, 2010
The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonistFrançois Baur, David Beattie, David Beer, et al.
Pageof 4